The Globe and Mail reports in its Wednesday edition that National Bank analyst Cameron Doerksen continues to rank Heroux-Devtek "outperform," with an unchanged share target of $19. The Globe's David Leeder writes that analysts on average target the shares at $19.10. Mr. Doerksen says in a note: "Supply chain issues and inflationary costs will remain ongoing challenges for Heroux-Devtek over the coming quarters, but we see throughput and margins progressively improving over the next two years. In the meantime, as we have noted, demand in both the defence and civil segments for Heroux-Devtek remains very strong, which is the primary factor supporting our 'outperform' rating. Valuation is also attractive: on our F2025 forecast (in which we forecast more normalized margins), Heroux-Devtek shares are trading at 7.9 times EV/EBITDA versus the aerospace supplier peer group at 11.6 times next year EV/EBITDA." The Globe reported on Jan. 12, 2022, that Mr. Doerksen continued to rate Heroux-Devtek "outperform." The shares were then going for $16.83. The Globe reported on Aug. 10, 2023, that Desjardins Securities analyst Benoit Poirier had reaffirmed his "buy" recommendation for Heroux-Devtek. It was then worth $15.70.